These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 28947697

  • 1. [Dental Implant Treatment in Patients Receiving Anti-resorptive Agents.].
    Kuroshima S.
    Clin Calcium; 2017; 27(10):1453-1459. PubMed ID: 28947697
    [Abstract] [Full Text] [Related]

  • 2. Evaluation of dental implants as a risk factor for the development of bisphosphonate-related osteonecrosis of the jaw in breast cancer patients.
    Matsuo A, Hamada H, Takahashi H, Okamoto A, Kaise H, Chikazu D.
    Odontology; 2016 Sep; 104(3):363-71. PubMed ID: 25956267
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Previously successful dental implants can fail when patients commence anti-resorptive therapy-a case series.
    Pogrel MA, Ruggiero SL.
    Int J Oral Maxillofac Surg; 2018 Feb; 47(2):220-222. PubMed ID: 28803735
    [Abstract] [Full Text] [Related]

  • 5. Periodontal Disease, Dental Implants, Extractions and Medications Related to Osteonecrosis of the Jaws.
    Shah NP, Katsarelis H, Pazianas M, Dhariwal DK.
    Dent Update; 2015 Nov; 42(9):878-80, 883-4, 887-89. PubMed ID: 26749795
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Osteonecrosis associated with dental implants in patients undergoing bisphosphonate treatment.
    Kwon TG, Lee CO, Park JW, Choi SY, Rijal G, Shin HI.
    Clin Oral Implants Res; 2014 May; 25(5):632-40. PubMed ID: 23278625
    [Abstract] [Full Text] [Related]

  • 8. Outcomes of placing dental implants in patients taking oral bisphosphonates: a review of 115 cases.
    Grant BT, Amenedo C, Freeman K, Kraut RA.
    J Oral Maxillofac Surg; 2008 Feb; 66(2):223-30. PubMed ID: 18201600
    [Abstract] [Full Text] [Related]

  • 9. Osteonecrosis of the Jaw in Patients Receiving Bone-Targeted Therapies: An Overview--Part I.
    Turner B, Drudge-Coates L, Ali S, Pati J, Nargund V, Ali E, Cheng L, Wells P.
    Urol Nurs; 2016 Feb; 36(3):111-6, 154. PubMed ID: 27501591
    [Abstract] [Full Text] [Related]

  • 10. Dramatic osteonecrosis of the jaw associated with oral bisphosphonates, periodontitis, and dental implant removal.
    Fernández Ayora A, Herion F, Rompen E, Reginster JY, Magremanne M, Lambert F.
    J Clin Periodontol; 2015 Feb; 42(2):190-5. PubMed ID: 25327450
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Distinct immunopathology in the early stages between different antiresorptives-related osteonecrosis of the jaw-like lesions in mice.
    Hayano H, Kuroshima S, Sasaki M, Tamaki S, Inoue M, Ishisaki A, Sawase T.
    Bone; 2020 Jun; 135():115308. PubMed ID: 32142911
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Denosumab-related osteonecrosis of the jaw: a case report and management based on pharmacokinetics.
    You Tm, Lee KH, Lee SH, Park W.
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2015 Nov; 120(5):548-53. PubMed ID: 26337218
    [Abstract] [Full Text] [Related]

  • 15. Intraindividual comparison of preoperative (99m)Tc-MDP SPECT/CT and intraoperative and histopathological findings in patients with bisphosphonate- or denosumab-related osteonecrosis of the jaw.
    Assaf AT, Zrnc TA, Remus CC, Adam G, Zustin J, Heiland M, Friedrich RE, Derlin T.
    J Craniomaxillofac Surg; 2015 Oct; 43(8):1461-9. PubMed ID: 26232916
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Osteonecrosis of the jaw induced by receptor activator of nuclear factor-kappa B ligand (Denosumab) - Review.
    de Oliveira CC, Brizeno LA, de Sousa FB, Mota MR, Alves AP.
    Med Oral Patol Oral Cir Bucal; 2016 Jul 01; 21(4):e431-9. PubMed ID: 26827069
    [Abstract] [Full Text] [Related]

  • 18. Canadian consensus practice guidelines for bisphosphonate associated osteonecrosis of the jaw.
    Khan AA, Sándor GK, Dore E, Morrison AD, Alsahli M, Amin F, Peters E, Hanley DA, Chaudry SR, Dempster DW, Glorieux FH, Neville AJ, Talwar RM, Clokie CM, Al Mardini M, Paul T, Khosla S, Josse RG, Sutherland S, Lam DK, Carmichael RP, Blanas N, Kendler D, Petak S, St-Marie LG, Brown J, Evans AW, Rios L, Compston JE, Canadian Association of Oral and Maxillofacial Surgeons.
    J Rheumatol; 2008 Jul 01; 35(7):1391-7. PubMed ID: 18528958
    [Abstract] [Full Text] [Related]

  • 19. Effect of local vs. systemic bisphosphonate delivery on dental implant fixation in a model of osteonecrosis of the jaw.
    Abtahi J, Agholme F, Sandberg O, Aspenberg P.
    J Dent Res; 2013 Mar 01; 92(3):279-83. PubMed ID: 23264610
    [Abstract] [Full Text] [Related]

  • 20. Is implant surgery a risk factor for osteonecrosis of the jaw in older adult patients with osteoporosis? A national cohort propensity score-matched study.
    Ryu JI, Kim HY, Kwon YD.
    Clin Oral Implants Res; 2021 Apr 01; 32(4):437-447. PubMed ID: 33452837
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.